Your browser is no longer supported. Please, upgrade your browser.
Settings
SNY [NASD]
Sanofi
Index- P/E9.11 EPS (ttm)5.78 Insider Own16.40% Shs Outstand2.54B Perf Week-3.00%
Market Cap133.81B Forward P/E11.98 EPS next Y4.39 Insider Trans0.00% Shs Float2.25B Perf Month-2.63%
Income14.52B PEG1.21 EPS next Q0.78 Inst Own8.00% Short Float0.20% Perf Quarter6.76%
Sales43.98B P/S3.04 EPS this Y324.80% Inst Trans12.26% Short Ratio3.47 Perf Half Y10.83%
Book/sh25.19 P/B2.09 EPS next Y16.22% ROA- Target Price63.88 Perf Year0.57%
Cash/sh- P/C- EPS next 5Y7.50% ROE- 52W Range44.76 - 55.00 Perf YTD8.29%
Dividend1.91 P/FCF- EPS past 5Y24.10% ROI14.20% 52W High-4.33% Beta0.57
Dividend %3.63% Quick Ratio- Sales past 5Y1.40% Gross Margin67.60% 52W Low17.56% ATR0.67
Employees99412 Current Ratio- Sales Q/Q-4.60% Oper. Margin23.30% RSI (14)47.87 Volatility0.99% 0.97%
OptionableYes Debt/Eq- EPS Q/Q-6.80% Profit Margin17.70% Rel Volume0.53 Prev Close52.86
ShortableYes LT Debt/Eq- EarningsApr 28 BMO Payout0.00% Avg Volume1.32M Price52.62
Recom1.00 SMA20-0.95% SMA500.53% SMA2005.52% Volume694,170 Change-0.45%
Jan-15-21Initiated Deutsche Bank Sell
Sep-29-20Initiated Berenberg Hold
Mar-17-20Upgrade Barclays Underweight → Equal Weight
Mar-11-20Upgrade Goldman Neutral → Buy
Feb-11-20Initiated SVB Leerink Mkt Perform
Jan-06-20Upgrade JP Morgan Neutral → Overweight
Sep-23-19Upgrade Guggenheim Neutral → Buy
Sep-20-19Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-03-19Initiated Bernstein Outperform
Aug-14-19Upgrade UBS Neutral → Buy
Dec-11-18Upgrade Jefferies Hold → Buy
Nov-01-18Upgrade Barclays Underweight → Equal Weight
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Neutral → Buy
Aug-10-18Upgrade Citigroup Neutral → Buy
Mar-23-18Upgrade Liberum Hold → Buy
Jan-23-18Downgrade Barclays Equal Weight → Underweight
Dec-06-17Downgrade BofA/Merrill Buy → Neutral
Dec-01-17Downgrade Morgan Stanley Overweight → Underweight
Nov-15-17Upgrade Barclays Underweight → Equal Weight
Jun-21-21 02:44PM  
12:21PM  
Jun-20-21 05:11AM  
Jun-18-21 03:27PM  
02:04PM  
09:45AM  
06:37AM  
Jun-17-21 03:07PM  
12:33PM  
06:00AM  
Jun-16-21 04:42PM  
01:48PM  
11:49AM  
09:57AM  
Jun-15-21 03:20PM  
03:04PM  
Jun-14-21 08:00PM  
01:47PM  
Jun-11-21 02:31PM  
03:00AM  
Jun-10-21 08:00PM  
Jun-09-21 02:50PM  
Jun-08-21 02:03PM  
Jun-07-21 02:10PM  
01:45PM  
12:00PM  
Jun-04-21 02:50PM  
02:34PM  
02:12PM  
12:08PM  
10:11AM  
01:00AM  
Jun-03-21 01:36PM  
11:30AM  
08:00AM  
05:52AM  
Jun-02-21 02:15PM  
06:00AM  
01:44AM  
Jun-01-21 02:57PM  
11:26AM  
10:27AM  
08:54AM  
06:45AM  
01:00AM  
May-31-21 12:00PM  
May-28-21 01:43PM  
08:48AM  
May-27-21 02:10PM  
12:12PM  
10:12AM  
08:39AM  
08:32AM  
08:07AM  
05:59AM  
01:30AM  
May-26-21 02:05PM  
May-25-21 02:44PM  
08:05AM  
May-24-21 04:13PM  
02:28PM  
01:51PM  
12:09PM  
08:11AM  
08:02AM  
06:49AM  
May-23-21 06:54AM  
May-21-21 01:43PM  
01:18PM  
12:31PM  
09:51AM  
May-20-21 01:58PM  
06:08AM  
May-19-21 05:45PM  
05:00PM  
01:49PM  
06:44AM  
May-18-21 10:45AM  
08:51AM  
08:41AM  
04:28AM  
May-17-21 04:30PM  
10:59AM  
10:00AM  
08:25AM  
07:07AM  
04:36AM  
01:51AM  
01:30AM  
01:30AM  
May-16-21 08:00PM  
May-15-21 09:48AM  
May-14-21 03:29PM  
01:40PM  
May-13-21 02:27PM  
02:16PM  
May-12-21 02:14PM  
06:20AM  
May-11-21 04:30PM  
02:09PM  
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. It also has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanofi10% OwnerJul 28Buy16.0081,2501,300,000520,125Jul 29 06:06 AM